Emerging Viral Disease and Orthopaedic Surgeons: COVID-19 PANDEMIC
Keywords:
COVID-19, pandemic, orthopaedic surgeonAbstract
Background: COVID-19 is caused by novel Coronavirus Severe Acute Respiratory Syndrome-Corona Virus (SARS-Cov-2). It is purported to have originated from bat in Wuhan province of China in December, 2019. The epidemic spreads rapidly, reaching a pandemic proportion in January, 2020. The economic implications of the pandemic and burden on health care are enormous. We, therefore, review the impact of this disease to orthopaedic practice.
Methods: A comprehensive review of the literature, using suitable keywords, such as COVID -19, viral disease, orthopaedic surgery, on the search engines of PUBMED, Google Scholar and SCOPUS in June 2020.
Results: The current treatment of COVID-19 is largely supportive. Lockdown, social distancing, are among many social preventive measures that had been adopted in an attempt to halt the spread of this disease. These Social adjustments, are achieving remarkable results. Intensive monitoring is key. Profound modifications had been made in all spheres of orthopaedic practice, suspending elective surgical cases and modifying the handling of inpatients and outpatients.
Conclusions: Globally, orthopaedic practice has been altered in elaborate terms, to accommodate peculiarities of this emerging viral disease, COVID-19. Whilst not neglecting the needs of our patients who depend on us for due care, strict precautions have been adopted to protect patients and health care workers or halt the spread of the disease.
References
National Center for Immunization and
Respiratory Diseases( NCIRD), Division of viral diseases.
Chan JF, Yuan S, Kok KH, Chu H, Yang J, Xing F, Liu J, Yip CC,, Poon RW, et al. (2020). A familiar cluster of pneumonia associated with 2019 novel coronavirus indicating person-person transmission: a study of a family cluster. Lancet. 395(10223):514-523
Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, Wang W, Song H, Huang B, ZhuN, et al( 2020). Genomic Characterization and epidemiology of 2019 novel coronavirus: implications of virus origins and receptor binding. Lancet 395(10224):565-574.
Mahase E. (2020). China coronavirus: WHO declare Int. emergency as death toll exceeds 200.
BMJ. 2020 Jan 31;368:m408. doi:
1136/bmj.m408.
WHO. DG's remarks @the media briefing on 2019-Cov on 11 feb (2020). Retrieved from: https://www.who.int/dg/speeches/detail/whodirector-general (Accessed on feb12, 2020).
Li Q, Guan X, Wu P, Wang X, Zhou L, Tong, et al
Jan (2020). Early transmission dynamics in Wuhan, China of novel coronavirus-infected pneumonia. N. Engl. J. Med. 382:1199-1207. DOI:10.1056/NEJMoa2001316.
Guan W-j, Ni Z-Y, Hu Y, Liang W-h, Ou c-q, He J, et al. Apr(2020) Clinical characteristics of 2019 novel coronavirus infection in China. N. Eng J.
M e d 3 8 2 : 1 7 0 8 - 1 7 2 0 .
DOI:10.1056/NEJMoa2002032.
Wu Z, Mc Coogan JM. Feb(2020) Characteristics of and importance lessons from the corona virus disease 2019(Covid 19) outbreak in China: Summary of report of 72,314 cases from the Chinese center of disease control and prevention. JAMA. Doi:10.1001/jama.2020.2648. Online
ahead of print
Park JY, Han MS, Park Ku, Kim JY, Choi EH. Mar (2020) First paediatric case of coronavirus disease in 2019 in Korea. J. Korean. Med.
Sci.35(11):e124.doi10.3346/jkms.2020.35.e124
Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al.Feb(2020) Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan,
C h i n a . J A M A . 3 2 3 ( 1 1 ) : 1 0 6 1 -
doi:10.1001/jama.2020.1585.
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Feb(2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet, 395(10223):497-506
Neeltje van Doremalen, phD.;Trenton
Bushmaker, BSc;et al;NEJM. Mar (2020) Aerosol and Surface stability of SARS-Cov-2 as compared with SARS-Cov-1;Doi10.1056/NEJMc2004973.
Van Doremalen N, Bushmaket T, Morris D. Aerosol and surface stability of Covid -19(SARS-
C o v - 2 ) c o m p a r e d t o S A R S -
Cov)medRxiv(2020);http//doi.org/10.1101/2020.
09.20033217
WHO. Advice on the use of masks in the Community, during home care and in healthcare settings in the context of the novel coronavirus
(2019nCov) outbreak. Jan 29,(2020).
https;//www.who.int./publications-detail/adviceon-the –use-of-mask-in-the-community-duringhome-care-and-in-the-healthcare-settings-in-thecontext-of-the-novel-coronavirus-(2019-nCov)outbreak.
Expert consensus on preventing nosocomial transmission during respiratory care for critically ill patients infected by 2019 novel coronavirus pneumonia. Zhonghua jie he he hu,xi, za zi =Zhonghua jiehe he huxi za zhi =Chinese journal o f T. B a n d r e s p i r a t o r y d i s e a s e s .
(2020);17(0);E020.
WHO. Coronavirus disease (Covid-2019) situation reports. March 27,(2020). h t t p s : / / w w w. w h o . i n t / d o c s / d e f a u l t source/coronavirus/situation-reports/20200327sitrep-67-covid-19.pdf?sfvrsn=b65f68eb_4
https://www.ecdc.europa.eu/sites/default/files/
styles/is_full/public/images/COVID-19geographical-distribution-world-cumulativen u m b e r - 1 4 - d a y - 2 0 2 0 - 0 5 -
jpg?itok=qgTK_JLX(Accessed May
,(2020)
Moriarty LF, Plucinski MM, Marston BJ. Public Health Responses to Covid-19 outbreaks on Cruise ships-Worldwide, Feb-Mar (2020) MMWR Morb. Mortal. Wkly Report.ePub;23 MR
(2020).DOI:http://dx.doi.org/10.155/mmwr.mar6 912e3external icon.
Baud D, Qi X, Nielsen-Saines K, Musso D. Pomar L, Favre G. Mar 12,(2020) Real estimates of mortality following Covid -19 infection, The Lancet infectious diseases. Online agead of print.
https://doi.org/10.1016/S1473-3099(20)30195-X
Mc Micheal TM, Currie DW, Clerk S, Pogosjans
S, Kay M, Schwartz NG, et al.(2020) Epid. Of Covid-19 in a long-term care Facility in king County, Washington. New Eng J. of Med. (2020)
The L. Covid-19: (2020) Protecting health-care workers. The Lancet.;395(10228):922
Punch Nigerian newspapers 1 mar, 2020
Siverdlow DL, Finelli . (2020), Preparation for possible sustained transmission of 2019 Novel coronavirus: Lessons from previous epidemics. Jama.323(12)1129-30
Livingstone E. Bucher K. (2020)Coronavirus
Disease 2019(Covid-19) in Italy.Jama.2020
Anwaerter PG. Coronavirus Covid-19(SARSCov-2). John Hopkins ABX Gude.
http://www.hopkinsguides.com/hopkins/view/jo h n s _ h o p k i n s _ A B X -
Guide/540747/all/coronavirus_covid_19__SAR
S-_Cov 2
Ou X, Liu Y, Lei X, Li P, Mi D, Ren L, et alMar(2020). Characterization of Spike glycoprotein of SARS-Cov-2 on virus entry and its immune cross-reactivity with SARS-Cov. Nat. Commun.11,1620(2020).10.1038/s41467-02015562-9.
Hoffman M; Kleine-Weber H; Schroeder S; Kruger N; Herrler T; Erichsen S; Schiergens ES; Herrler G; Wu N-H; Nitsche A; Muller MA; Drosten C; Pohlman S. Apr(2020) SARS-Cov-2 cell entry depends on ACE2 and TRMPSS2 and is blocked by a clinically proven protease inhibitor.
C e l l 1 8 1 ( 2 ) : 2 7 1 - 2 8 0 . e 8 . doi:10.1016/j.cell.2020.02.052.
Zou X., Chen K., Zou J., Han P., Hao J., Han Z. Mar(2020) Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019nCoV infection. Frontiers of Medicine 14,185-
(2020)
Hamming I., Timens W., Bulthuis M.L., Lely A.T., Navis G., van Goor H.June (2004) Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. Journal of Pathol. 203(2):631–637.
Jia H.P, Look D.C., Shi L., Hickey M., Pewe L., Netland J., Farzan M., Wohlford-Lenane C., Perlman S., McCray P.B Jr. (2005)ACE2 receptor expression and severe acute respiratory syndrome coronavirus infection depend on differentiation of human airway epithelia. Journal of Virology. Dec
(23):14614–14621.doi:10.1128/JVI.79.23.146 14-14621.2005.
Channappanavar R., Zhao J., Perlman S.(2014) T cell-mediated immune response to respiratory c o r o n a v i r u s e s . J o u r n a l .
(1):118–128.doi:10.1007/s12026-014-8534-z
Zhou Y., Fu B., Zheng X., Wnag D., Zhao C., Qi Y., Sun R., Tian Z., Xu X., Wei H. Mar (2020) Pathogenic T cells and inflammatory monocytes incite inflammatory storm in severe COVID-19 patients. National Science Review, nwaa041, https://.org/10.1093/nsr/nwaa041
Qin C., Zhou L., Hu Z., Zhang S., Yang S., Tao Y., Xie C., Ma K., Shang K., Wang W., Tian D.S.(2020) Dysregulation of immune response in patients with COVID-19 in Wuhan, China. Clinical Infectious diseasesl. ;ciaa248. doi:
1093/cid/ciaa248. Online ahead of print.
Fujimoto I., Pan J., Takizawa T., Nakanishi Y. Apr(2000) Virus clearance through apoptosisdependent phagocytosis of influenza A virusinfected cells by macrophages. Journal of
V i r o l o g y . 7 4 ( 7 ) : 3 3 9 9 – 4 0 3 .
Doi:10.1128/jvi.74.7.3399-3403
Xu Z., Shi L., Wang Y., Zhang J., Huang L., Zhang C., Liu S., Zhao P., Liu H., Zhu L., Tai Y., Bai C.,
Gao T., Song J., Xia P., Dong J., Zhao J. Apr (2020) Wang F.S. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. The Lancet Journal. 8(4):420–422.
Tian S., Hu W., Niu L., Liu H., Xu H., Xiao S.Y.May (2020) Pulmonary pathology of Earlyphase 2019 Novel Coronavirus (COVID-19) pneumonia in two patients with lung cancer. Journal of Thoracic oncology. 15(5):700-704doi: 10.1016/j.jtho.2020.02.010.
Liu S., Su X., Pan P., Zhang L., Hu Y., Tan H., Wu D., Liu B., Li H., Li H., Li Y., Dai M., Li Y., Hu C., Tsung A. Nov(2016) Neutrophil extracellular t r a p s a r e i n d i r e c t l y t r i g g e r e d b y
lipopolysaccharide and contribute to acute lung injury. 6:37252.doi:10.10.38/srep37252
Koutsogiannaki S., Shimaoka M., Yuki K. (2019) The use of volatile anesthetics as sedatives for acute respiratory distress syndrome. Tranl Perioper Pain Med 6(2):27–38. Doi:
31480/2330-4871/084. Epub 2019 Feb 21
Fang M., Siciliano N.A., Hersperger A.R., Roscoe
F., Hu A., Ma X., Shamsedeen A.R., Eisenlohr L.C., Sigal L.J.(2012) Perforin-dependent CD4+ T-cell cytotoxicity contributes to control a murine poxvirus infection. Proc Natl Acad Sci USA.
(25):9983–8.doi:10.1073/pnas.1202143190 9.
Small B.A., Dressel S.A., Lawrence C.W., Drake D.R., 3rd, Stoler M.H., Enelow R.I., Braciale T.J. (2001) CD8(+) T cell-mediated injury in vivo progresses in the absence of effector T cells. Journal.194(12):1835–1846.doi:10.1084/jem.19
12.1835
Lovren F., Pan Y., Quan A., Teoh H., Wang G., Shukla P.C., Levitt K.S., Oudit G.Y., Al-Omran M., Stewart D.J., Slutsky A.S., Oct(2008) Peterson M.D., Backx P.H., Penninger J.M., Verma S. Angiotensin converting enzyme-2 confers endothelial protection and attenuates atherosclerosis. Am J. Physiol Heart Circ
P h y s i o l . 2 9 5 ( 4 ) : H 1 3 7 7 – H 1 3 8 4 .
Doi10.1152/ajpheart.00331.2008
Sluimer J.C., Gasc J.M., Hamming I., van Goor
H., Michaud A., van den Akker L.H., Jutten B., Cleutjens J., Bijnens A.P., Corvol P., Daemen M.J., Heeneman S.(2008) Angiotensin-converting enzyme 2 (ACE2) expression and activity in human carotid atherosclerotic lesions. J. Pathol.;215(3):273–279.doi:10.1002/path.2357.
Zeng H., Pappas C., Belser J.A., Houser K.V., Zhong W., Wadford D.A., Stevens T., Balczon R.,
Katz J.M., Tumpey T.M.(2012) Human pulmonary microvascular endothelial cells support productive replication of highly pathogenic avian influenza viruses: possible involvement in the pathogenesis of human H5N1 v i r u s i n f e c t i o n . J . V i r o l .
(2):667–678.doi:10.1128/JVI.06348-11.
Wang M., Hao H., Leeper N.J., Zhu L., Early Career C. June(2018). Thrombotic regulation from the endothelial cell perspectives. A r t e r i o s c l e r T h r o m b Va s c B i o l .
(6):e90–e95.doi:10.1161/ATVBAHA.118.310 367.
Bhadra S, Jiang YS, Kumar MR, Johnson RF, Hensley LE, Ellington AD. Apr(2015) Real time sequence-validated loop-mediated isothermal amplification assays for detection of middle East respiratory syndrome coronavirus(MERS-Cov) 10(4):e0123126.doi:10:1371/journal.pone.01231 26.eCollection 2015.
Chan JF, Choi GK, Tsang AK, Tee KM, Lam HY, Yip CC.(2015) Development and evaluation of novel coronavirus real time reverse transcriptionPCR Assays with locked nucleic acid probes targeting leader sequences of human pathogenic coronaviruses. J. Clin. Microbiol. 53:2722-
doi10.1128/JCM.01224-15
Huang P, Wang H, Cao Z, Jin H, Chi H, Zhao J.(2018) A rapid and specific Assay for the detection of MERS-Cov. Front Microbiol. 9:1101.doi.10.3389/fmicb.2018.01101
Lee SH, Baek Y.H, Kim YH, Choi YK, Song MS, Ahn JY. Jan(2017) One pot reverse transcriptional loop-mediated isothermal amplification (RTLAMP) for detecting MERS-Cov. Front
M i c r o b i o l .
:2166.doi:10.3389/fmicb.2016.02166.eCollecti on 2016
Chu DKW, Pan Y, Cheng SMS, Hiu KPY,
Krishnan P, Liu Y. Apr (2020) Molecular diagnosis of a novel coronavirus(2019-nCov) causing an outbreak of pneumonia. Clin.Chem 66(4:)549-
doi:10.1093/clinchem/hvaa029
VM Corman, O.Landt, M. Kaiser et al. Detection of 2019 novel coronavirus(2019 –nCov) by real time RT-PCR Euro Surveill. 25(3):2000045. h t t p s : / / d o i . o r g / 1 0 . 2 8 0 7 / 1 5 6 0 -
ES.2020.25.3.2000045.
Cordes AK, Heim A. Feb (2020) Rapid random access detection of the novel SARS coronavirus2(SARS-Cov-2, previously 2019-nCov) using an open access protocol for the Panther fusion. J Clin
V i r o l . 1 2 5 : 1 0 4 3 0 5 .
Doi.10.1016/j.jcv.2020.104305.
How to cite this article:
Xie X, Zhong Z, Zhao W, Zheng C, Wang F, Liu J. Feb (2020) Chest CT for typical 2019-nCov pneumonia: relationship to negative RT-PCR t e s t i n g . R a d i o l . https://doi.org/10.1148/radiol.2020200343.
Ai T, Yang Z, Hon H, Zhan C, Chen C, Lv W. Feb(2020) Correlation of chest CT and RT-PCR testing in coronavirus disease2019(Covid-19) CT and RT-PCR testing in coronavirus
disease(Covid-19) in China: A report of 1014 c a s e s . R a d i o l . https://doi.org/10.1148/radiol.2020200642.
Chung M, Bernheim A, Mei X, Zhang, Huang M, Zeng X. Feb (2020) Ct Imaging features of 2019 novel coronavirus (2019) Radiol.295, No 1 https://doi.org/10.1148/radiol.202020030.
Shi H, Han X, Jiang N, Cao Y, Alwulid O, Gu J.Feb (2020) Radiological findings from 81 patients with Covid-19 pneumonia in Wuhan, China: a descriptive study. Lancet infect Dis.20(4):425434. DOI:https://doi.org/10.1016/S1473-33099 (20)30086-4.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Research Journal of Health Sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Research Journal of Health Sciences journal is a peer reviewed, Open Access journal. The Journal subscribed to terms and conditions of Open Access publication. Articles are distributed under the terms of Creative Commons License (CC BY-NC-ND 4.0). (http://creativecommons.org/licences/by-nc-nd/4.0). All articles are made freely accessible for everyone to read, download, copy and distribute as long as appropriate credit is given and the new creations are licensed under the identical terms.
